AraƱador, Edson C.
HRN: 28-36-72 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/04/2026
01/10/2026
IV
500
Q8
ACUTE CHOLANGITIS Tc Septic Ileus
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes